Health, KIT Royal Tropical Institute, Amsterdam, The Netherlands
Tropical Diseases, Institute of Tropical Medicine, Antwerp, Belgium.
BMJ Glob Health. 2020 Oct;5(10). doi: 10.1136/bmjgh-2020-003236.
Research integrity and research fairness have gained considerable momentum in the past decade and have direct implications for global health epidemiology. Research integrity and research fairness principles should be equally nurtured to produce high-quality impactful research-but bridging the two can lead to practical and ethical dilemmas. In order to provide practical guidance to researchers and epidemiologist, we set out to develop good epidemiological practice guidelines specifically for global health epidemiology, targeted at stakeholders involved in the commissioning, conduct, appraisal and publication of global health research.
We developed preliminary guidelines based on targeted online searches on existing best practices for epidemiological studies and sought to align these with key elements of global health research and research fairness. We validated these guidelines through a Delphi consultation study, to reach a consensus among a wide representation of stakeholders.
A total of 45 experts provided input on the first round of e-Delphi consultation and 40 in the second. Respondents covered a range of organisations (including for example academia, ministries, NGOs, research funders, technical agencies) involved in epidemiological studies from countries around the world (Europe: 19; Africa: 10; North America: 7; Asia: 5; South-America: 3 Australia: 1). A selection of eight experts were invited for a face-to-face meeting. The final guidelines consist of a set of 6 standards and 42 accompanying criteria including study preparation, protocol development, data collection, data management, data analysis, dissemination and communication.
While guidelines will not by themselves guard global health from questionable and unfair research practices, they are certainly part of a concerted effort to ensure not only mutual accountability between individual researchers, their institutions and their funders but most importantly their joint accountability towards the communities they study and society at large.
研究诚信和研究公平在过去十年中得到了相当大的重视,它们直接影响到全球健康流行病学。研究诚信和研究公平原则应该得到同等培养,以产生高质量有影响力的研究——但将两者联系起来可能会导致实际和道德上的困境。为了为研究人员和流行病学家提供实践指导,我们专门为全球健康流行病学制定了良好的流行病学实践指南,针对参与委托、进行、评估和发表全球健康研究的利益相关者。
我们根据现有的流行病学研究最佳实践的有针对性的在线搜索,制定了初步的指南,并试图将这些指南与全球健康研究和研究公平的关键要素保持一致。我们通过德尔菲咨询研究对这些指南进行了验证,以在广泛的利益相关者中达成共识。
共有 45 名专家对第一轮电子德尔菲咨询提供了意见,第二轮有 40 名专家提供了意见。受访者涵盖了来自世界各地的参与流行病学研究的各种组织(包括例如学术界、部委、非政府组织、研究资助者、技术机构)(欧洲:19;非洲:10;北美:7;亚洲:5;南美洲:3;澳大利亚:1)。邀请了八名专家参加面对面会议。最终的指南包括一套 6 项标准和 42 项配套标准,涵盖研究准备、方案制定、数据收集、数据管理、数据分析、传播和沟通。
虽然指南本身并不能防止全球健康领域出现有问题和不公平的研究实践,但它们肯定是确保不仅研究人员个人、他们的机构和资助者之间相互问责,而且最重要的是他们对研究社区和整个社会的共同问责的协调努力的一部分。